ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Clovis Oncology Inc

Clovis Oncology Inc (CLVS)

0.0812
0.00
(0.00%)
Closed October 01 4:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.0812
Bid
0.0792
Ask
0.0811
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.0812
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

CLVS Latest News

Clovis Oncology Shares Fall Premarket After Bankruptcy Filing

By Colin Kellaher Shares of Clovis Oncology Inc. slid nearly 10% in premarket trading Monday after the biopharmaceutical company said it filed for chapter 11 bankruptcy with plans to auction off...

Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286

Receives Commitment for up to $75 Million in Debtor-in-Possession Financing Clovis Oncology, Inc. (NASDAQ:CLVS) (“Clovis” or the Company”), a biopharmaceutical company focused on acquiring...

Clovis Oncology Presents Data from TRITON3 Phase 3 Trial of Rubraca® (rucaparib) at the 29th Annual Prostate Cancer Foundation Scientific Retreat

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced the presentation of data from the TRITON3 Phase 3 trial in men with metastatic castration-resistant prostate cancer with BRCA or ATM...

Clovis Oncology Highlights Updated LuMIERE Phase 1 Data of Targeted Radiotherapy Candidate FAP-2286 at the 35th Annual EANM Congress

Updated LuMIERE Phase 1 data demonstrated a manageable safety profile with some preliminary evidence of anti-tumor activity Eleven patients treated to date with 177Lu-FAP-2286 up to 7.4 GBq/dose...

TRITON3 Phase 3 Trial of Rubraca® (rucaparib) Achieves Primary Endpoint in Men with Metastatic Castration-Resistant Prostate Cancer with BRCA or ATM Mutations

TRITON3 study evaluating Rubraca monotherapy versus chemotherapy or second-line androgen deprivation therapy in patients with metastatic castration-resistant prostate cancer (mCRPC) with...

Clovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply Agreement

Isotopia to supply its medical radioisotope, lutetium-177, for the clinical development of Clovis Oncology’s targeted radionuclide therapy candidate FAP-2286 Clovis Oncology, Inc. (NASDAQ: CLVS...

Clovis Oncology Submits Applications for Rubraca® Label Expansion in the US and European Union as First-line Maintenance Treatment in Women with Advanced Ovarian Cancer

Submissions based on data from the Phase 3 ATHENA trial evaluating Rubraca monotherapy versus placebo (ATHENA-MONO) presented at ASCO 2022 The ATHENA-MONO trial met its primary endpoint, showing...

Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk Subgroups

Subgroup analysis from the Phase 3 ATHENA trial evaluating Rubraca monotherapy versus placebo (ATHENA-MONO) presented in a Mini Oral session at the ESMO Congress 2022 Results reinforce potential...

Clovis Oncology Announces Second Quarter 2022 Operating Results and Provides Update on Clinical Development Programs

First presentation of initial LuMIERE Phase 1 clinical data for FAP-2286 targeted radiotherapy candidate at SNMMI demonstrated a manageable safety profile with preliminary evidence of activity...

CORRECTING and REPLACING Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8

First paragraph, second sentence of release should read: Clovis’ senior management will host a conference call and live audio webcast at 8:30am ET to discuss Clovis’ results and business outlook...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PAVSParanovus Entertainment Technology Ltd
$ 0.9001
(87.52%)
4.33M
JWELJowell Global Ltd
$ 2.5399
(45.05%)
325.84k
MGRXMangoceuticals Inc
$ 0.3183
(34.87%)
188.76M
GDEVGDEV Inc
$ 33.02
(34.72%)
20.24k
XCHXCHG Ltd
$ 13.60
(33.46%)
198.88k
GRTSGritstone bio Inc
$ 0.2213
(-61.84%)
29.85M
APDNApplied DNA Sciences Inc
$ 0.3402
(-47.64%)
14.82M
STTKShattuck Labs Inc
$ 1.9291
(-44.72%)
10.35M
GHSIGuardion Health Sciences Inc
$ 3.24
(-41.52%)
673.3k
KXINKaixin Holdings
$ 0.1264
(-35.31%)
33.7M
NVDANVIDIA Corporation
$ 117.00
(-3.66%)
276M
SQQQProShares UltraPro Short QQQ
$ 7.72
(4.47%)
195.44M
MGRXMangoceuticals Inc
$ 0.3183
(34.87%)
188.76M
HOLOMicroCloud Hologram Inc
$ 0.3911
(8.64%)
173.13M
DUOFangDD Network Group Ltd
$ 3.38
(9.03%)
144.93M

Discussion

View Full Feed
BDEZ BDEZ 3 minutes ago
You would know buddy...
Hitman970 Hitman970 3 minutes ago
I know the feeling in many tickers!
RMTD
frrol frrol 4 minutes ago
- We have apparently not applied for conditional approval. So we would not get AA via that route.
- If after their full evaluation the CHMP has concerns, they can: (1) recommend not approving our MAA, or (2) they could recommend a conditional approval. Note that #2 is after the evaluation, so
AVXL
WALL STREET KID WALL STREET KID 4 minutes ago
https://www.youtube.com/watch?v=GZ-0wDC5rX8
AMC
Smilin_B Smilin_B 4 minutes ago
Shares Outstanding 29.81M
Shares Float 17.39M
Short Float 16.57%
Short Interest 2.88M

https://finviz.com/quote.ashx?t=IMPP&p=d
IMPP
peanutz peanutz 5 minutes ago
Learn to read . Everything has changed . They are a start up mining company . Infrastructure contractor and builder . Read the fine print .
HIRU
MC10459 MC10459 6 minutes ago
Broke resistance. Next stop is .02
MGON
janice shell janice shell 6 minutes ago
Now..maybe he is on the write-in list....!

I think he should be.
learningcurve2020 learningcurve2020 6 minutes ago
LOL. I've said a dozen times here that I got the pub wrong but you dopes still try to club me with it just to make your own lousy records look a little better. Meanwhile JAMA is becoming ancient history. But the two dozen things I've called right there's no mention, of course.
NWBO
Pranksalot Pranksalot 7 minutes ago
Gee whiz! Thank you for the encouragement and support 🙂
ELTP
SSKILLZ1 SSKILLZ1 7 minutes ago
~~COMPX 10/2/2024~~~~~~~

Previous Close

17,910.36 -278.81

17799 SSKILLZ1
COMP
peanutz peanutz 7 minutes ago
R/S coming soon . Drag
TPTW
crazy horse 0 crazy horse 0 8 minutes ago
At times these people let the rank they have go to their head

Officials are turning HELP away from the people that desperately need it
op1 op1 8 minutes ago
Ha ha
Epic in wddd world a penny stock on the otcqb
Ha ha
Guess if the price goes up significantly it could be epic
Good luck hunting
WDDD
vinnie1965 vinnie1965 9 minutes ago
TGRP will run very hard and fast, virtually no one will be able to stop it. The Drag Queen from Canada is spewing his nonsense as usual, one that is also afraid of his own shadow flips a tick at or at best a penny at a time, there is nothing you can do with a mind that has been conditioned to that
TGRP
Pranksalot Pranksalot 9 minutes ago
Thank you for your kind words and encouragement!

You’re correct, the adage of “all the eggs in one” may be dangerous so therefore I did put a small percentage in a few other stocks and a small amount in a money money fund for a rainy day… And if all things fail, I can dumpster dive f
ELTP
cjstocksup cjstocksup 9 minutes ago
https://x.com/elonmusk/status/1841206529418055964
waterchaser waterchaser 9 minutes ago
A swing and a miss.

Thanks for trying to answer my question to mascale.

Neither of you hit the mark.

Miro’s involvement in HIRU continues to be a problem.
HIRU
peanutz peanutz 10 minutes ago
They can flush me out for a penny lol !
RSPI
fuagf fuagf 10 minutes ago
It's not easy to campaign against a habitual liar. It's doubly difficult when often the lies aren't even planned, when things so ludicrously stupid as the lie Trump tells there about the immigration app being linked to cartel heads, telling them where to drop the refugees they are transporting of
BDEZ BDEZ 10 minutes ago
Yup! Very....
Slojab Slojab 10 minutes ago
Good for trading but the restricted shares has the market cap at $44,419,811.
ASPZ
MasterBlastr MasterBlastr 10 minutes ago
That doesn't make sense.
AMC
cjstocksup cjstocksup 11 minutes ago
https://x.com/elonmusk/status/1841207137420132549

Your Recent History

Delayed Upgrade Clock